Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Rigel Pharmaceuticals Inc (NasdaqNM:RIGL)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Reports
Location
240 East Grand Avenue
South San Francisco, CA 94080
Phone: (650) 624-1100
Fax: (650) 624-1101
Employees (last reported count): 107
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 56%
·Institutional: 9% (20% of float)
(23 institutions)
·Net Inst. Buying: 793.0K shares (+19.05%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Rigel Pharmaceuticals, Inc. is a drug discovery company that utilizes combinatorial biology to discover novel drug targets and drug candidates that regulate these targets. In four years of research using its technology, the Company has initiated 12 programs through which it has identified several new drug targets in 11 of its programs, and has generated compounds in six programs. Rigel has programs in asthma/allergy, autoimmunity, transplant rejection, rheumatoid arthritis, inflammatory bowel disease, chronic bronchitis, cancerous tumor growth and hepatitis C. The Company's technologies are designed to identify protein targets for compound screening and validate the role of those targets in the disease process.
More from Market Guide: Expanded Business Description

Financial Summary
Rigel Pharmaceuticals, Inc. is engaged in the discovery and development of a broad range of new small molecule drug candidates. The company uses post-genomics combinatorial biology technology to discover novel drug targets. For the six months ended 6/30/01, revenues fell 7% to $6.3 million. Net loss applicable to Common fell 49% to $11.5 million. Results reflect the absence of payments received from a partner, offset by the absence of preferred dividends.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

James Gower, 52
Pres, CEO, Director
$268K--  
Brian Cunningham, 57
COO, Chief Financial Officer, Sr. VP, Sec.
258K$2.0M
Donald Payan, M.D., 52
Exec. VP and CSO
247K--  
James Welch, 43
VP of Fin. and Admin., Assistant Sec.
154K161K
Raul Rodriguez, 40
VP-Bus. Devel.
177K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:RIGLAs of 31-Aug-2001
Price and Volume
52-Week Low
on 4-Apr-2001
$3.25 
Recent Price$5.49 
52-Week High
on 3-Jan-2001
$12.75 
Daily Volume (3-month avg)80.0K
Daily Volume (10-day avg)47.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
26-Week Change-8.5%
26-Week Change
relative to S&P500
-0.4%
Share-Related Items
Market Capitalization$205.9M
Shares Outstanding37.5M
Float16.5M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$1.08 
Earnings (ttm)-$2.60 
Earnings (mrq)-$0.20 
Sales (ttm)$0.54 
Cash (mrq)$1.10 
Valuation Ratios
Price/Book (mrq)5.08 
Price/EarningsN/A 
Price/Sales (ttm)10.20 
Income Statements
Sales (ttm)$12.7M
EBITDA (ttm)-$18.0M
Income available to common (ttm)-$26.0M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-57.87%
Return on Equity (ttm)-85.13%
Financial Strength
Current Ratio (mrq)6.30 
Debt/Equity (mrq)0.22 
Total Cash (mrq)$41.3M
Short Interest
As of 8-Aug-2001
Shares Short52.0K
Percent of Float0.3%
Shares Short
(Prior Month)
327.0K
Short Ratio1.27 
Daily Volume41.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.